Testing effectiveness (Phase 2)Study completedNCT04241601
What this trial is testing
Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
Who this might be right for
Acute Coronary Syndromes
Cambridge University Hospitals NHS Foundation Trust 60